{"filing":{"accession_number":"0001104659-26-065991","cik":"0001787297","ticker":"PASG","company_name":"Passage BIO, Inc.","form":"8-K","filing_date":"2026-05-26","report_date":null,"primary_document":"tm2615548d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1787297/000110465926065991/tm2615548d1_8k.htm"},"events":[{"id":8951,"run_id":7857,"accession_number":"0001104659-26-065991","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of Passage Bio's 2026 Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes on four proposals: election of two Class III directors (Athena Countouriotis, M.D. and Sandip Kapadia), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The filing presents vote tallies (For, Against, Abstaining, Broker Non-Votes) for each proposal, making this a classic shareholder_vote_results disclosure.","company_name":"Passage BIO, Inc.","ticker":"PASG","filing_date":"2026-05-26","form":"8-K","submitted_at":null,"items":[{"id":1413,"accession_number":"0001104659-26-065991","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Passage Bio's 2026 Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes on four proposals: election of two Class III directors (Athena Countouriotis, M.D. and Sandip Kapadia), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The filing presents vote tallies (For, Against, Abstaining, Broker Non-Votes) for each proposal, making this a classic shareholder_vote_results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:07:09.487542+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1413,"accession_number":"0001104659-26-065991","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Passage Bio's 2026 Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes on four proposals: election of two Class III directors (Athena Countouriotis, M.D. and Sandip Kapadia), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The filing presents vote tallies (For, Against, Abstaining, Broker Non-Votes) for each proposal, making this a classic shareholder_vote_results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-27T02:07:09.487542+00:00","company_name":"Passage BIO, Inc.","ticker":"PASG","filing_date":"2026-05-26"}]}